Nutra Pharma Corp (NPHC) Capital Expenditures (2010 - 2025)

Nutra Pharma has disclosed Capital Expenditures across 7 years of filings, most recently posting $26052.0 for Q1 2025.

• In Q1 2025, Capital Expenditures changed N/A year-over-year to $26052.0; the TTM figure through Dec 2025 stood at $26052.0 (changed N/A YoY), while the FY2025 annual figure was $26052.0, changed N/A from the prior year.
• Capital Expenditures came in at $26052.0 for Q1 2025 at Nutra Pharma, down from $57993.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $57993.0 in Q1 2022 to a low of $4275.0 in Q4 2021.
• Average Capital Expenditures over 3 years is $20514.7, with a median of $15082.0 recorded in 2021.
• The largest YoY upside for Capital Expenditures was 482.84% in 2022 against a maximum downside of 482.84% in 2022.
• Over 3 years, Capital Expenditures stood at $4275.0 in 2021, then soared by 1256.56% to $57993.0 in 2022, then plunged by 55.08% to $26052.0 in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $26052.0 in Q1 2025, $57993.0 in Q1 2022, and $4275.0 in Q4 2021.